English
简体中文
Total: £ 56.28
Published Date: 2026-01-20 | Pages: 110 | Tables: 103 | Medical Care
The global Widely-targeted Metabolomics market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 522 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Widely targeted metabolome is a metabolome detection technology that integrates the advantages of non-targeted and targeted metabolite detection technologies.The widely targeted metabolome can compare the types and abundance differences of metabolites between different samples, screen out significant differences in metabolites with important biological significance between different groups, and qualitatively and quantitatively detect low-abundance trace-level compounds.
The North American market for Widely-targeted Metabolomics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Widely-targeted Metabolomics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Widely-targeted Metabolomics in Academic and Research Institutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Widely-targeted Metabolomics include Creative Dynamics Inc (Creative Proteomics), Lifeasible, BGI Genomics, Metware Biotechnology Inc (Metware), TianGen, Gene Denovo, SHANGHAI OE Biotech, ShangHai Biotree, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Widely-targeted Metabolomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Widely-targeted Metabolomics. The Widely-targeted Metabolomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Widely-targeted Metabolomics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Widely-targeted Metabolomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Creative Dynamics Inc (Creative Proteomics)
Lifeasible
BGI Genomics
Metware Biotechnology Inc (Metware)
TianGen
Gene Denovo
SHANGHAI OE Biotech
ShangHai Biotree
Segment by Type
Plant Widely-targeted Metabolomics
Animal Widely-targeted Metabolomics
Segment by Application
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Widely-targeted Metabolomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Widely-targeted Metabolomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Plant Widely-targeted Metabolomics
1.2.3 Animal Widely-targeted Metabolomics
1.3 Market by Application
1.3.1 Global Widely-targeted Metabolomics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Academic and Research Institutions
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Widely-targeted Metabolomics Market Perspective (2021–2032)
2.2 Global Widely-targeted Metabolomics Growth Trends by Region
2.2.1 Global Widely-targeted Metabolomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Widely-targeted Metabolomics Historic Market Size by Region (2021–2026)
2.2.3 Widely-targeted Metabolomics Forecasted Market Size by Region (2027–2032)
2.3 Widely-targeted Metabolomics Market Dynamics
2.3.1 Widely-targeted Metabolomics Industry Trends
2.3.2 Widely-targeted Metabolomics Market Drivers
2.3.3 Widely-targeted Metabolomics Market Challenges
2.3.4 Widely-targeted Metabolomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Widely-targeted Metabolomics Players by Revenue
3.1.1 Global Top Widely-targeted Metabolomics Players by Revenue (2021–2026)
3.1.2 Global Widely-targeted Metabolomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Widely-targeted Metabolomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Widely-targeted Metabolomics Revenue
3.4 Global Widely-targeted Metabolomics Market Concentration Ratio
3.4.1 Global Widely-targeted Metabolomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Widely-targeted Metabolomics Revenue in 2025
3.5 Global Key Players of Widely-targeted Metabolomics Head Offices and Areas Served
3.6 Global Key Players of Widely-targeted Metabolomics, Products and Applications
3.7 Global Key Players of Widely-targeted Metabolomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Widely-targeted Metabolomics Breakdown Data by Type
4.1 Global Widely-targeted Metabolomics Historic Market Size by Type (2021–2026)
4.2 Global Widely-targeted Metabolomics Forecasted Market Size by Type (2027–2032)
5 Widely-targeted Metabolomics Breakdown Data by Application
5.1 Global Widely-targeted Metabolomics Historic Market Size by Application (2021–2026)
5.2 Global Widely-targeted Metabolomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Widely-targeted Metabolomics Market Size (2021–2032)
6.2 North America Widely-targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Widely-targeted Metabolomics Market Size by Country (2021–2026)
6.4 North America Widely-targeted Metabolomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Widely-targeted Metabolomics Market Size (2021–2032)
7.2 Europe Widely-targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Widely-targeted Metabolomics Market Size by Country (2021–2026)
7.4 Europe Widely-targeted Metabolomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Widely-targeted Metabolomics Market Size (2021–2032)
8.2 Asia-Pacific Widely-targeted Metabolomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Widely-targeted Metabolomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Widely-targeted Metabolomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Widely-targeted Metabolomics Market Size (2021–2032)
9.2 Latin America Widely-targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Widely-targeted Metabolomics Market Size by Country (2021–2026)
9.4 Latin America Widely-targeted Metabolomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Widely-targeted Metabolomics Market Size (2021–2032)
10.2 Middle East & Africa Widely-targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Widely-targeted Metabolomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Widely-targeted Metabolomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Dynamics Inc (Creative Proteomics)
11.1.1 Creative Dynamics Inc (Creative Proteomics) Company Details
11.1.2 Creative Dynamics Inc (Creative Proteomics) Business Overview
11.1.3 Creative Dynamics Inc (Creative Proteomics) Widely-targeted Metabolomics Introduction
11.1.4 Creative Dynamics Inc (Creative Proteomics) Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.1.5 Creative Dynamics Inc (Creative Proteomics) Recent Development
11.2 Lifeasible
11.2.1 Lifeasible Company Details
11.2.2 Lifeasible Business Overview
11.2.3 Lifeasible Widely-targeted Metabolomics Introduction
11.2.4 Lifeasible Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.2.5 Lifeasible Recent Development
11.3 BGI Genomics
11.3.1 BGI Genomics Company Details
11.3.2 BGI Genomics Business Overview
11.3.3 BGI Genomics Widely-targeted Metabolomics Introduction
11.3.4 BGI Genomics Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.3.5 BGI Genomics Recent Development
11.4 Metware Biotechnology Inc (Metware)
11.4.1 Metware Biotechnology Inc (Metware) Company Details
11.4.2 Metware Biotechnology Inc (Metware) Business Overview
11.4.3 Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Introduction
11.4.4 Metware Biotechnology Inc (Metware) Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.4.5 Metware Biotechnology Inc (Metware) Recent Development
11.5 TianGen
11.5.1 TianGen Company Details
11.5.2 TianGen Business Overview
11.5.3 TianGen Widely-targeted Metabolomics Introduction
11.5.4 TianGen Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.5.5 TianGen Recent Development
11.6 Gene Denovo
11.6.1 Gene Denovo Company Details
11.6.2 Gene Denovo Business Overview
11.6.3 Gene Denovo Widely-targeted Metabolomics Introduction
11.6.4 Gene Denovo Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.6.5 Gene Denovo Recent Development
11.7 SHANGHAI OE Biotech
11.7.1 SHANGHAI OE Biotech Company Details
11.7.2 SHANGHAI OE Biotech Business Overview
11.7.3 SHANGHAI OE Biotech Widely-targeted Metabolomics Introduction
11.7.4 SHANGHAI OE Biotech Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.7.5 SHANGHAI OE Biotech Recent Development
11.8 ShangHai Biotree
11.8.1 ShangHai Biotree Company Details
11.8.2 ShangHai Biotree Business Overview
11.8.3 ShangHai Biotree Widely-targeted Metabolomics Introduction
11.8.4 ShangHai Biotree Revenue in Widely-targeted Metabolomics Business (2021–2026)
11.8.5 ShangHai Biotree Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Widely-targeted Metabolomics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Plant Widely-targeted Metabolomics
Table 3. Key Players of Animal Widely-targeted Metabolomics
Table 4. Global Widely-targeted Metabolomics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Widely-targeted Metabolomics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Widely-targeted Metabolomics Market Size by Region (US$ Million), 2021–2026
Table 7. Global Widely-targeted Metabolomics Market Share by Region (2021–2026)
Table 8. Global Widely-targeted Metabolomics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Widely-targeted Metabolomics Market Share by Region (2027–2032)
Table 10. Widely-targeted Metabolomics Market Trends
Table 11. Widely-targeted Metabolomics Market Drivers
Table 12. Widely-targeted Metabolomics Market Challenges
Table 13. Widely-targeted Metabolomics Market Restraints
Table 14. Global Widely-targeted Metabolomics Revenue by Players (US$ Million), 2021–2026
Table 15. Global Widely-targeted Metabolomics Market Share by Players (2021–2026)
Table 16. Global Top Widely-targeted Metabolomics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Widely-targeted Metabolomics Revenue, 2025
Table 17. Ranking of Global Top Widely-targeted Metabolomics Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Widely-targeted Metabolomics Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Widely-targeted Metabolomics, Headquarters and Area Served
Table 20. Global Key Players of Widely-targeted Metabolomics, Products and Applications
Table 21. Global Key Players of Widely-targeted Metabolomics, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Widely-targeted Metabolomics Market Size by Type (US$ Million), 2021–2026
Table 24. Global Widely-targeted Metabolomics Revenue Market Share by Type (2021–2026)
Table 25. Global Widely-targeted Metabolomics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Widely-targeted Metabolomics Revenue Market Share by Type (2027–2032)
Table 27. Global Widely-targeted Metabolomics Market Size by Application (US$ Million), 2021–2026
Table 28. Global Widely-targeted Metabolomics Revenue Market Share by Application (2021–2026)
Table 29. Global Widely-targeted Metabolomics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Widely-targeted Metabolomics Revenue Market Share by Application (2027–2032)
Table 31. North America Widely-targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Widely-targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
Table 33. North America Widely-targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Widely-targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Widely-targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Widely-targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Widely-targeted Metabolomics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Widely-targeted Metabolomics Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Widely-targeted Metabolomics Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Widely-targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Widely-targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Widely-targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Widely-targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Widely-targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Widely-targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
Table 46. Creative Dynamics Inc (Creative Proteomics) Company Details
Table 47. Creative Dynamics Inc (Creative Proteomics) Business Overview
Table 48. Creative Dynamics Inc (Creative Proteomics) Widely-targeted Metabolomics Product
Table 49. Creative Dynamics Inc (Creative Proteomics) Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 50. Creative Dynamics Inc (Creative Proteomics) Recent Development
Table 51. Lifeasible Company Details
Table 52. Lifeasible Business Overview
Table 53. Lifeasible Widely-targeted Metabolomics Product
Table 54. Lifeasible Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 55. Lifeasible Recent Development
Table 56. BGI Genomics Company Details
Table 57. BGI Genomics Business Overview
Table 58. BGI Genomics Widely-targeted Metabolomics Product
Table 59. BGI Genomics Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 60. BGI Genomics Recent Development
Table 61. Metware Biotechnology Inc (Metware) Company Details
Table 62. Metware Biotechnology Inc (Metware) Business Overview
Table 63. Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Product
Table 64. Metware Biotechnology Inc (Metware) Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 65. Metware Biotechnology Inc (Metware) Recent Development
Table 66. TianGen Company Details
Table 67. TianGen Business Overview
Table 68. TianGen Widely-targeted Metabolomics Product
Table 69. TianGen Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 70. TianGen Recent Development
Table 71. Gene Denovo Company Details
Table 72. Gene Denovo Business Overview
Table 73. Gene Denovo Widely-targeted Metabolomics Product
Table 74. Gene Denovo Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 75. Gene Denovo Recent Development
Table 76. SHANGHAI OE Biotech Company Details
Table 77. SHANGHAI OE Biotech Business Overview
Table 78. SHANGHAI OE Biotech Widely-targeted Metabolomics Product
Table 79. SHANGHAI OE Biotech Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 80. SHANGHAI OE Biotech Recent Development
Table 81. ShangHai Biotree Company Details
Table 82. ShangHai Biotree Business Overview
Table 83. ShangHai Biotree Widely-targeted Metabolomics Product
Table 84. ShangHai Biotree Revenue in Widely-targeted Metabolomics Business (US$ Million), 2021–2026
Table 85. ShangHai Biotree Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Widely-targeted Metabolomics Picture
Figure 2. Global Widely-targeted Metabolomics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Widely-targeted Metabolomics Market Share by Type: 2025 vs 2032
Figure 4. Plant Widely-targeted Metabolomics Features
Figure 5. Animal Widely-targeted Metabolomics Features
Figure 6. Global Widely-targeted Metabolomics Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Widely-targeted Metabolomics Market Share by Application: 2025 vs 2032
Figure 8. Academic and Research Institutions Case Studies
Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
Figure 10. Contract Research Organizations Case Studies
Figure 11. Widely-targeted Metabolomics Report Years Considered
Figure 12. Global Widely-targeted Metabolomics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Widely-targeted Metabolomics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Widely-targeted Metabolomics Market Share by Region: 2025 vs 2032
Figure 15. Global Widely-targeted Metabolomics Market Share by Players in 2025
Figure 16. Global Widely-targeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Widely-targeted Metabolomics Revenue in 2025
Figure 18. North America Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Widely-targeted Metabolomics Market Share by Country (2021–2032)
Figure 20. United States Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Widely-targeted Metabolomics Market Share by Country (2021–2032)
Figure 24. Germany Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Widely-targeted Metabolomics Market Share by Region (2021–2032)
Figure 32. China Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Widely-targeted Metabolomics Market Share by Country (2021–2032)
Figure 40. Mexico Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Widely-targeted Metabolomics Market Share by Country (2021–2032)
Figure 44. Israel Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Widely-targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Creative Dynamics Inc (Creative Proteomics) Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 48. Lifeasible Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 49. BGI Genomics Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 50. Metware Biotechnology Inc (Metware) Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 51. TianGen Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 52. Gene Denovo Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 53. SHANGHAI OE Biotech Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 54. ShangHai Biotree Revenue Growth Rate in Widely-targeted Metabolomics Business (2021–2026)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
